封面
市場調查報告書
商品編碼
1378700

介入性腫瘤消融市場:按技術、按適應症、按最終用戶、按地區

Interventional Oncology Ablation Market, By Technology, By Indication, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 389 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球介入性腫瘤消融市場預計到 2023 年將達到 5.337 億美元,預測期內(2023-2030 年)年複合成長率為 8.7%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 5.337 億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 8.70% 2030年市場規模預測 9.595 億美元
圖 1. 2023 年按技術分類的介入性腫瘤消融的全球市場佔有率(%)
介入性腫瘤消融市場-IMG1

介入性腫瘤消融涉及用於局部癌症治療的微創、影像引導程序。消融技術主要有兩種:熱消融和非熱消融。熱療,例如射頻消融 (RFA)、微波消融和冷凍消融,使用熱能或冷能來破壞癌細胞。 RFA利用高頻電流產生熱量並誘發腫瘤凝固性壞死。它廣泛用於治療肝、腎、肺和骨腫瘤。微波消融利用電磁微波攪拌水分子並產生摩擦熱來消融組織。冷凍消融透過冷卻探針施加極低的溫度來冷凍並破壞病灶組織。非熱方法包括不可逆電穿孔,它應用短電脈衝在細胞膜上產生奈米孔,導致細胞凋亡。消融治療微創、恢復快、副作用少、可重複。非常適合無法手術的癌症、不適合手術的患者以及轉移性/復發性腫瘤。持續的進展集中在提高消融區域的尺寸和精度。高強度聚焦超音波消融、動態療法和奈米粒子介導的消融等新興技術也顯示出擴大介入性腫瘤治療的前景。

市場動態

市場上癌症患者的不斷增加預計將推動預測期內全球介入性腫瘤消融市場的成長。例如,根據美國臨床腫瘤學會(ASCO)發布的資料,到2023年2月,美國將有超過380萬名女性患有或未患有乳癌。 2023年,美國將有297,790名女性被診斷出患有侵襲性乳癌,55,720名女性將被診斷出患有原位乳癌,43,700名女性將死於乳癌(預計有43,170名女性和530名男性)。

本研究的主要特點

  • 本報告對全球介入性腫瘤消融市場進行了詳細分析,並列出了以2022年為基準年的預測期(2023-2030年)的市場規模和年複合成長率。
  • 它還揭示了各個細分市場的潛在商機,並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、績效和策略等參數,介紹了全球介入性腫瘤消融治療市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
  • 全球介入性腫瘤消融市場報告針對該行業的各個相關人員,如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球介入性腫瘤消融市場的各種策略矩陣來促進他們的決策。

目錄

第1章 調查目的和假設

  • 這項研究的目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、法規及趨勢分析

    • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
    • 影響分析
    • 最近測試啟動
    • 流行病學
    • 合併、收購和合作
    • 法規場景
    • 主要進展
    • PEST分析

第4章 全球介入性腫瘤消融市場-COVID-19影響分析

    • 經濟影響
    • 新型冠狀病毒感染疾病(COVID-19)的流行病學
    • 對需求和供給的影響

第5章 2018-2030年全球介入性腫瘤消融市場(依技術)

  • 射頻消融術
  • 微波消融
  • 冷凍
  • 不可逆電穿孔消融

第6章 2018-2030年全球介入性腫瘤消融市場(依適應症)

  • 肝癌
  • 腎癌
  • 肺癌
  • 其他

第7章 全球介入性腫瘤消融市場,依最終用戶分類,2018-2030

  • 醫院和診所
  • 門診手術中心
  • 其他

第8章 2018-2030年全球介入性腫瘤消融市場(按地區)

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭形勢

  • 公司簡介
    • Boston Scientific Corporation
    • Johnson &Johnson
    • Medtronic Plc
    • Varian Medical Systems, Inc.
    • EDAP TMS SA
    • AngioDynamics
    • CASCINATION AG
    • Merit Medical Systems, Inc.
    • STARmed Co.
    • Biomedical Srl

第10章 章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4445

The global interventional oncology ablation market is estimated to be valued at US$ 533.7 Million in 2023 and is expected to exhibit a CAGR of 8.7% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 533.7 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 8.70% 2030 Value Projection: US$ 959.5 Mn
Figure 1. Global Interventional Oncology Ablation Market Share (%), By Technology, 2023
Interventional Oncology Ablation Market - IMG1

Interventional oncology ablation involves minimally invasive, image-guided procedures to deliver localized cancer treatment. There are two main types of ablation techniques: thermal and non-thermal. Thermal techniques like radiofrequency ablation (RFA), microwave ablation, and cryoablation use heat or cold energy to destroy cancer cells. RFA uses high-frequency electrical currents to generate heat and induce tumor coagulation necrosis. It is widely used for treating liver, kidney, lung, and bone tumors. Microwave ablation applies electromagnetic microwaves to agitate water molecules and produce frictional heat to ablate tissue. Cryoablation freezes and destroys diseased tissue by applying extremely cold temperatures through cooled probes. Non-thermal techniques include irreversible electroporation, which applies short electric pulses to form nanopores in cell membranes, leading to apoptosis. Ablation therapies are minimally invasive, allow for quicker recovery, have fewer side effects, and can be performed repeatedly. They are ideal for inoperable cancers, patients unfit for surgery, and metastatic or recurrent tumors. Ongoing advances focus on improving ablation zone size and precision. Emerging techniques like high-intensity focused ultrasound ablation, photodynamic therapy, and nanoparticle-mediated ablation also show promise in expanding interventional oncology treatment.

Market Dynamics

The constantly increasing number of cancer patients in the market is expected to drive growth of the global interventional oncology ablation market over the forecast period. For instance, in February 2023, according to data published by the American Society of Clinical Oncology (ASCO), there were more than 3.8 million women living with or beyond breast cancer in the U.S. In 2023, an estimated 297,790 women in the U. S. will be diagnosed with invasive breast cancer, 55,720 women will be diagnosed with non-invasive (in situ) breast cancer, and 43,700 deaths (43,170 women and 530 men) from breast cancer will occur in the U.S.

Key features of the study:

  • This report provides an in-depth analysis of the global interventional oncology ablation market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global interventional oncology ablation market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, Inc., EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems, Inc., STARmed Co., and Biomedical Srl.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global interventional oncology ablation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interventional oncology ablation market

Interventional Oncology Ablation Market Detailed Segmentation:

  • By Technology:
    • Radiofrequency Ablation
    • Microwave Ablation
    • Cryoablation
    • Irreversible Electroporation Ablation
  • By Indication:
    • Liver Cancer
    • Kidney Cancer
    • Lung Cancer
    • Others
  • By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Boston Scientific Corporation
    • Johnson & Johnson
    • Medtronic Plc
    • Varian Medical Systems, Inc.
    • EDAP TMS S.A.
    • AngioDynamics
    • CASCINATION AG
    • Merit Medical Systems, Inc.
    • STARmed Co.
    • Biomedical Srl.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Indication
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Recent Test Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis

4. Global Interventional Oncology Ablation Market - COVID-19 Impact Analysis

    • Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand

5. Global Interventional Oncology Ablation Market, By Technology, 2018- 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Radiofrequency Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Mn)
    • Segment Trends
  • Microwave Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Cryoablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Irreversible Electroporation Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends

6. Global Interventional Oncology Ablation Market, By Indication, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Liver Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Kidney Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends

7. Global Interventional Oncology Ablation Market, By End User, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

8. Global Interventional Oncology Ablation Market, By Region, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • Boston Scientific Corporation*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Medtronic Plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Varian Medical Systems, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • EDAP TMS S.A.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • AngioDynamics
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • CASCINATION AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Merit Medical Systems, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • STARmed Co.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Biomedical Srl
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact